Clinical Trial Update: Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma [Phase 1]

View source ↗

Summary

A phase 1 clinical trial evaluating HER2-targeted CAR-T cells for advanced sarcoma is ongoing, sponsored by Baylor College of Medicine (status: active, not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• HER2 CAR-T cells

Snippet

Sponsor: Baylor College of Medicine | Conditions: Sarcoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING